Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HARE-40: BNT113 in HPV16+ Carcinoma
NCT03418480Phase 2Completed
- Sponsor
- University of Southampton
- Start
- Apr 2017
- Primary completion
- Nov 2023
- Modality
- Vaccines & Immunotherapeutics, mRNA Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of BNT113 in HPV-related carcinoma, head and neck squamous cell carcinoma (HNSCC), cervical carcinoma, penile carcinoma, Ano-genital Carcinoma, sponsored by University of Southampton. Started Apr 2017; status: completed.
02
Drugs
BNT113
03
Conditions
HPV-related carcinomahead and neck squamous cell carcinoma (HNSCC)cervical carcinomapenile carcinomaAno-genital Carcinoma
Beyond the preview
Go deeper on NCT03418480.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03418480.